Brought to you by 
Wyeth, Impax settle patent litigation surrounding Effexor
25 Aug 2008
Executive Summary
Wyeth and Impax Laboratories (generics and branded pharmaceuticals) have settled US patent infringement litigation that began in 2006 surrounding Impax's generic capsule version of Wyeth's Effexor XR antidepressant.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Includes Contract
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Wyeth, Impax settle patent litigation surrounding Effexor
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice